| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 135, Issue 5 3151-3162, Copyright © 1985 by American Association of Immunologists
ARTICLES |
JS McDougal, A Mawle, SP Cort, JK Nicholson, GD Cross, JA Scheppler-Campbell, D Hicks and J Sligh
In cultures of normal human lymphocytes infected with the human retrovirus HTLV-III/LAV, detectable cytoplasmic virus appears and then disappears in a proportion (1 to 10%) of cells, followed by release of virus detected by particulate reverse transcriptase activity, virus antigen assay, and infectivity titer. Virus infection is associated with loss of detectable T4 antigen on infected cells and, ultimately, complete loss of T4+ cells from the culture. Residual non-T4+ cells are not susceptible to a second infection with HTLV-III/LAV, and in cultures of separated cell populations, substantial virus replication occurred in T4+ T cells and minimally, if at all, in non-T4+ cells. We could not detect a disproportionate loss of cell surface phenotype (other than T4) in comparison of infected and noninfected cultures of lymphocytes or purified T4+ T cells when these cultures were monitored with a panel of monoclonal antibodies that detect the major mononuclear cell types (alpha-T11, alpha-T3, alpha-Mo2, alpha-B1), functional T cell subsets (alpha-T8, alpha-Leu-8, alpha-T17), or activated/proliferating cells (alpha-T10, alpha-Ia, alpha-T9, alpha- 4F2, alpha-Tac). HTLV-III/LAV replication was quantitatively greatest in lymphocytes stimulated with phytohemagglutinin (PHA) and cultured in the presence of interleukin 2 (IL 2). Once activated by PHA, virus production in nondividing (irradiated) cells was similar to that in nonirradiated cells, but was substantially reduced if radiation was performed before PHA stimulation. Omission of PHA, IL 2, or both resulted in progressively lower amounts of virus replication. However, virus replication was detected and T4+ T cell depletion occurred in all cultures, regardless of medium supplement or radiation. T4+ T cells absorb infectious virus, and the binding of HTLV-III/LAV to the surface of T4+ T cells, but not to non-T4+ cells, was directly demonstrated. Binding is equivalent in activated and nonactivated cells and at 4 degrees and 37 degrees C. Reciprocal inhibition of binding was observed with alpha-T4a monoclonal antibody and virus. Exposure of cells to alpha-T4a before and during HTLV-III/LAV inoculation inhibited subsequent virus replication. We conclude that T4+ T cells are the major target for HTLV-III/LAV replication, that this tropism is related to expression of the T4 antigen that serves as a binding site for virus, that infection is inexorable in T4+ T cells regardless of subset or activation state, and that the activation/proliferative state of the cells is not a necessary determinant of infectivity, but rather, determines the amount of replication that will ensue.
This article has been cited by other articles:
|
|
 |
|
  M. S. Giri, M. Nebozhyn, L. Showe, and L. J. Montaner Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006 J. Leukoc. Biol., November 1, 2006; 80(5): 1031 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nishimura, T. Igarashi, O. K. Donau, A. Buckler-White, C. Buckler, B. A. P. Lafont, R. M. Goeken, S. Goldstein, V. M. Hirsch, and M. A. Martin Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses PNAS, August 17, 2004; 101(33): 12324 - 12329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Veazey, J. D. Lifson, I. Pandrea, J. Purcell, M. Piatak Jr., and A. A. Lackner Simian Immunodeficiency Virus Infection in Neonatal Macaques J. Virol., August 15, 2003; 77(16): 8783 - 8792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. U. Vogel, H. Horton, D. H. Fuller, D. K. Carter, K. Vielhuber, D. H. O'Connor, T. Shipley, J. Fuller, G. Sutter, V. Erfle, et al. Differences Between T Cell Epitopes Recognized After Immunization and After Infection J. Immunol., October 15, 2002; 169(8): 4511 - 4521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Giguere, J.-S. Paquette, S. Bounou, R. Cantin, and M. J. Tremblay New Insights into the Functionality of a Virion-Anchored Host Cell Membrane Protein: CD28 Versus HIV Type 1 J. Immunol., September 1, 2002; 169(5): 2762 - 2771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Pierson, Y. Zhou, T. L. Kieffer, C. T. Ruff, C. Buck, and R. F. Siliciano Molecular Characterization of Preintegration Latency in Human Immunodeficiency Virus Type 1 Infection J. Virol., July 29, 2002; 76(17): 8518 - 8531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Veazey, K. G. Mansfield, I. C. Tham, A. C. Carville, D. E. Shvetz, A. E. Forand, and A. A. Lackner Dynamics of CCR5 Expression by CD4+ T Cells in Lymphoid Tissues during Simian Immunodeficiency Virus Infection J. Virol., December 1, 2000; 74(23): 11001 - 11007. [Abstract] [Full Text]
|
|
|
|
|
|
G. J. Wiegers, I. E. M. Stec, W. E. F. Klinkert, and J. M. H. M. Reul Glucocorticoids Regulate TCR-Induced Elevation of CD4: Functional Implications J. Immunol., June 15, 2000; 164(12): 6213 - 6220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Veazey, I. C. Tham, K. G. Mansfield, M. DeMaria, A. E. Forand, D. E. Shvetz, L. V. Chalifoux, P. K. Sehgal, and A. A. Lackner Identifying the Target Cell in Primary Simian Immunodeficiency Virus (SIV) Infection: Highly Activated Memory CD4+ T Cells Are Rapidly Eliminated in Early SIV Infection In Vivo J. Virol., January 1, 2000; 74(1): 57 - 64. [Abstract] [Full Text]
|
|
|
|
|
|
N. M. Ferguson, F. deWolf, A. C. Ghani, C. Fraser, C. A. Donnelly, P. Reiss, J. M. A. Lange, S. A. Danner, G. P. Garnett, J. Goudsmit, et al. Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy PNAS, December 21, 1999; 96(26): 15167 - 15172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Little, A. R. McLean, C. A. Spina, D. D. Richman, and D. V. Havlir Viral Dynamics of Acute HIV-1 Infection J. Exp. Med., September 20, 1999; 190(6): 841 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Hengel, B. M. Jones, M. S. Kennedy, M. R. Hubbard, and J. S. McDougal Markers of Lymphocyte Homing Distinguish CD4 T Cell Subsets That Turn Over in Response to HIV-1 Infection in Humans J. Immunol., September 15, 1999; 163(6): 3539 - 3548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Glushakova, J.-C. Grivel, K. Suryanarayana, P. Meylan, J. D. Lifson, R. Desrosiers, and L. Margolis Nef Enhances Human Immunodeficiency Virus Replication and Responsiveness to Interleukin-2 in Human Lymphoid Tissue Ex Vivo J. Virol., May 1, 1999; 73(5): 3968 - 3974. [Abstract] [Full Text]
|
|
|
|
|
|
S. W. Cole, Y. D. Korin, J. L. Fahey, and J. A. Zack Norepinephrine Accelerates HIV Replication Via Protein Kinase A-Dependent Effects on Cytokine Production J. Immunol., July 15, 1998; 161(2): 610 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Veazey, M. DeMaria, L. V. Chalifoux, D. E. Shvetz, D. R. Pauley, H. L. Knight, M. Rosenzweig, R. P. Johnson, R. C. Desrosiers, and A. A. Lackner Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection Science, April 17, 1998; 280(5362): 427 - 431. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Gualberto, G. Marquez, M. Carballo, G. L. Youngblood, S. W. Hunt III, A. S. Baldwin, and F. Sobrino p53 Transactivation of the HIV-1 Long Terminal Repeat Is Blocked by PD 144795, a Calcineurin-Inhibitor with Anti-HIV Properties J. Biol. Chem., March 20, 1998; 273(12): 7088 - 7093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Wessner, P. C. Shick, J.-H. Lu, C. B. Cardellichio, S. E. Gagneten, N. Beauchemin, K. V. Holmes, and G. S. Dveksler Mutational Analysis of the Virus and Monoclonal Antibody Binding Sites in MHVR, the Cellular Receptor of the Murine Coronavirus Mouse Hepatitis Virus Strain A59 J. Virol., March 1, 1998; 72(3): 1941 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Chou, O. Ramilo, and E. S. Vitetta Highly purified CD25- resting T cells cannot be infected de novo with HIV-1 PNAS, February 18, 1997; 94(4): 1361 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Chirmule, H. Goonewardena, S. Pahwa, R. Pasieka, V. S. Kalyanaraman, and S. Pahwa HIV-1 Envelope Glycoproteins Induce Activation of Activated Protein-1 in CD4+ T Cells J. Biol. Chem., August 18, 1995; 270(33): 19364 - 19369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pantaleo, C. Graziosi, and A. S. Fauci The Immunopathogenesis of Human Immunodeficiency Virus Infection N. Engl. J. Med., February 4, 1993; 328(5): 327 - 335. [Full Text]
|
|
|
|
|
|
S. Hwang, T. Boyle, H. Lyerly, and B. Cullen Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1 Science, July 24, 1992; 257(5069): 535 - 537. [Abstract] [PDF]
|
|
|
|
|
|
P. Cameron, P. Freudenthal, J. Barker, S Gezelter, K Inaba, and R. Steinman Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells Science, July 17, 1992; 257(5068): 383 - 387. [Abstract] [PDF]
|
|
|
|
|
|
D. Cohen, Y Tani, H Tian, E Boone, L. Samelson, and H. Lane Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1 Science, April 24, 1992; 256(5056): 542 - 545. [Abstract] [PDF]
|
|
|
|
|
|
M. Bukrinsky, T. Stanwick, M. Dempsey, and M Stevenson Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection Science, October 18, 1991; 254(5030): 423 - 427. [Abstract] [PDF]
|
|
|
|
|
|
J. Harouse, S Bhat, S. Spitalnik, M Laughlin, K Stefano, D. Silberberg, and F Gonzalez-Scarano Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide Science, July 19, 1991; 253(5017): 320 - 323. [Abstract] [PDF]
|
|
|
|
|
|
C. Hart, C. Ou, J. Galphin, J Moore, L. Bacheler, J. Wasmuth, S. Petteway Jr, and G Schochetman Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells Science, October 27, 1989; 246(4929): 488 - 491. [Abstract] [PDF]
|
|
|
|
|
|
S. Schnittman, M. Psallidopoulos, H. Lane, L Thompson, M Baseler, F Massari, C. Fox, N. Salzman, and A. Fauci The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4 Science, July 21, 1989; 245(4915): 305 - 308. [Abstract] [PDF]
|
|
|
|
|
|
J. Hildreth and R. Orentas Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation Science, June 2, 1989; 244(4908): 1075 - 1078. [Abstract] [PDF]
|
|
|
|
|
|
B Hoyos, D. Ballard, E Bohnlein, M Siekevitz, and W. Greene Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression Science, April 28, 1989; 244(4903): 457 - 460. [Abstract] [PDF]
|
|
|
|
|
|
T. Folks, S. Kessler, J. Orenstein, J. Justement, E. Jaffe, and A. Fauci Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow Science, November 11, 1988; 242(4880): 919 - 922. [Abstract] [PDF]
|
|
|
|
|
|
L. Kong, S. Lee, J. Kappes, J. Parkin, D Decker, J. Hoxie, B. Hahn, and G. Shaw West African HIV-2-related human retrovirus with attenuated cytopathicity Science, June 10, 1988; 240(4858): 1525 - 1529. [Abstract] [PDF]
|
|
|
|
|
|
J. Zack, A. Cann, J. Lugo, and I. Chen HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation Science, May 20, 1988; 240(4855): 1026 - 1029. [Abstract] [PDF]
|
|
|
|
|
|
B. Franza Jr, F. Rauscher 3rd, S. Josephs, and T Curran The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites Science, March 4, 1988; 239(4844): 1150 - 1153. [Abstract] [PDF]
|
|
|
|
|
|
A. Fauci The human immunodeficiency virus: infectivity and mechanisms of pathogenesis Science, February 5, 1988; 239(4840): 617 - 622. [Abstract] [PDF]
|
|
|
|
|
|
D. Smith, R. Byrn, S. Marsters, T Gregory, J. Groopman, and D. Capon Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen Science, December 18, 1987; 238(4834): 1704 - 1707. [Abstract] [PDF]
|
|
|
|
|
|
M Siekevitz, S. Josephs, M Dukovich, N Peffer, F Wong-Staal, and W. Greene Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I Science, December 11, 1987; 238(4833): 1575 - 1578. [Abstract] [PDF]
|
|
|
|
|
|
M. Lee, D. Ho, and M. Gurney Functional interaction and partial homology between human immunodeficiency virus and neuroleukin Science, August 28, 1987; 237(4818): 1047 - 1051. [Abstract] [PDF]
|
|
|
|
|
|
J. Hoxie, J. Alpers, J. Rackowski, K Huebner, B. Haggarty, A. Cedarbaum, and J. Reed Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV Science, November 28, 1986; 234(4780): 1123 - 1127. [Abstract] [PDF]
|
|
|
|
|
|
B Tourvieille, S. Gorman, E. Field, T Hunkapiller, and Parnes JR Isolation and sequence of L3T4 complementary DNA clones: expression in T cells and brain Science, October 31, 1986; 234(4776): 610 - 614. [Abstract] [PDF]
|
|
|
|
|
|
J. McDougal, M. Kennedy, J. Sligh, S. Cort, A Mawle, and J. Nicholson Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule Science, January 24, 1986; 231(4736): 382 - 385. [Abstract] [PDF]
|
|
|
|
 |
|
 J.S. McDougal, P.J. Maddon, A.G. Dalgleish, P.R. Clapham, D.R. Littman, M. Godfrey, D.E. Maddon, L. Chess, R.A. Weiss, and R. Axel The T4 Glycoprotein Is a Cell-surface Receptor for the AIDS Virus Cold Spring Harb Symp Quant Biol, January 1, 1986; 51(0): 703 - 711. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
